Home/Filings/4/0001179110-18-008992
4//SEC Filing

Koestler Thomas P 4

Accession 0001179110-18-008992

CIK 0001235010other

Filed

Jun 24, 8:00 PM ET

Accepted

Jun 25, 4:29 PM ET

Size

16.4 KB

Accession

0001179110-18-008992

Insider Transaction Report

Form 4
Period: 2018-06-20
Transactions
  • Exercise/Conversion

    Restricted Stock Units

    2018-06-205,7340 total
    Common Stock (5,734 underlying)
  • Exercise/Conversion

    Common Stock

    2018-06-20+5,73411,234 total
  • Award

    Stock Option (Right to Buy)

    2018-06-20+8,8558,855 total
    Exercise: $22.30Exp: 2028-06-20Common Stock (8,855 underlying)
  • Award

    Restricted Stock Units

    2018-06-20+4,3564,356 total
    Common Stock (4,356 underlying)
Footnotes (5)
  • [F1]Represents an option granted by the Company pursuant to the Company's 2013 Incentive Award Plan. The stock option will vest and become exercisable on the first anniversary of the grant date, subject to Dr. Koestler's continued service to the Company.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of MNTA common stock.
  • [F3]Represents 4,356 restricted stock units, awarded pursuant to the Company's 2013 Incentive Award Plan, 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Dr. Koestler's continued service to the Company.
  • [F4]Restricted Stock Units convert into common stock on a one-for-one basis.
  • [F5]Subject to certain criteria, 100% of the restricted stock units shall vest on the first anniversary of the grant date.

Issuer

MOMENTA PHARMACEUTICALS INC

CIK 0001235010

Entity typeother

Related Parties

1
  • filerCIK 0001373605

Filing Metadata

Form type
4
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 4:29 PM ET
Size
16.4 KB